<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03195920</url>
  </required_header>
  <id_info>
    <org_study_id>2017-02</org_study_id>
    <nct_id>NCT03195920</nct_id>
  </id_info>
  <brief_title>Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease</brief_title>
  <official_title>Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Applaud Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Applaud Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single arm, single center study to assess the safety and efficacy of a form of&#xD;
      extracorporeal lithotripsy, called the Enhanced Lithotripsy System, to treat urinary stones.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single arm, single center study to assess the safety and efficacy of a form of&#xD;
      extracorporeal lithotripsy, called the Enhanced Lithotripsy System, to treat urinary stones.&#xD;
      Subjects will be treated up to 2 times with the Enhanced Lithotripsy System and followed for&#xD;
      30 days after the last treatment session.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Interim data was sufficient for study purpose&#xD;
  </why_stopped>
  <start_date type="Actual">July 22, 2017</start_date>
  <completion_date type="Actual">August 30, 2021</completion_date>
  <primary_completion_date type="Actual">June 25, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single arm trial with the Enhanced Lithotripsy System</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of subjects with serious device-related adverse events (safety)</measure>
    <time_frame>30 days after last treatment session</time_frame>
    <description>Safety: Proportion of subjects with serious device-related adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Successful treatment of urinary stone</measure>
    <time_frame>14 days after last treatment session</time_frame>
    <description>Proportion of subjects with successful treatment or urinary stone</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in pain score</measure>
    <time_frame>Baseline and Post Procedure Days 1, 2, 3, 7, 14, and 30</time_frame>
    <description>Pelvic Pain of the Patient (Min - Zero, Max - 10), Higher score means more pain</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to passage of stones</measure>
    <time_frame>30 days after last treatment session</time_frame>
    <description>Post-Treatment time to passage of stone fragments after treatment</description>
  </other_outcome>
  <other_outcome>
    <measure>Pain medication usage</measure>
    <time_frame>Baseline and Days 1, 2, 3, 7, 14, and 30</time_frame>
    <description>Use and quantity of pain medication</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Urinary Stone</condition>
  <arm_group>
    <arm_group_label>Enhanced Lithotripsy System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment for urinary stones with the Enhanced Lithotripsy System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enhanced Lithotripsy System</intervention_name>
    <description>The Enhanced Lithotripsy System is a type of lithotripsy system comprising a console, treatment head, and Acoustic Energy Focusing material. Operation of the Enhanced Lithotripsy System entails combined action of extracorporeal insonation and Acoustic Energy Focusing material to fragment urinary stones.</description>
    <arm_group_label>Enhanced Lithotripsy System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals presenting with one urinary stone-apparent on a computed tomography scan&#xD;
             within the last 14 days&#xD;
&#xD;
          -  Males and females aged 18 or older&#xD;
&#xD;
          -  Capable of giving informed consent, and willing to have the informed consent process&#xD;
             videotaped&#xD;
&#xD;
          -  Stone size, as estimated by pre-operative computed tomography, with all dimensions 15&#xD;
             mm or less.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals under 18 years of age&#xD;
&#xD;
          -  Individuals with radiolucent stones&#xD;
&#xD;
          -  Individuals with stones in the lower pole of kidney&#xD;
&#xD;
          -  Individuals not following up in the treating hospital&#xD;
&#xD;
          -  Individuals with history of cystinuria&#xD;
&#xD;
          -  Individuals with urine pH below 5.5&#xD;
&#xD;
          -  Individuals with untreated urinary tract infection&#xD;
&#xD;
          -  Individuals who are not willing to use adequate method of contraception during the&#xD;
             study period&#xD;
&#xD;
          -  Women who are pregnant, lactating or planning pregnancy during the study period&#xD;
&#xD;
          -  Individuals with a coagulation abnormality or taking prescription anticoagulants.&#xD;
&#xD;
          -  Individuals with mobility issues who are unable to comfortably lie still for up to 30&#xD;
             minutes or roll from their back to their side&#xD;
&#xD;
          -  Individuals belonging to a vulnerable group (pregnant, mentally disabled, physically&#xD;
             disabled, prisoner, etc.)&#xD;
&#xD;
          -  Individuals with a body mass index greater than 35&#xD;
&#xD;
          -  Individuals with ASA score of 3 or greater general anesthesia risk level&#xD;
&#xD;
          -  Known sensitivity to possible medications used before, during, or after the treatment&#xD;
             procedure, including but not limited to the following: sedative agents, general&#xD;
             anesthetics, topical anesthetics, and opioid analgesics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahesh Desai, MS, FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Muljibhai Patel Urological Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Muljibhai Patel Urological Hospital</name>
      <address>
        <city>Nadiad</city>
        <state>Gujarat</state>
        <zip>387 001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 20, 2017</study_first_submitted>
  <study_first_submitted_qc>June 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Calculi</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

